Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 03, 2023

BUY
$118.38 - $210.04 $131,875 - $233,984
1,114 New
1,114 $200,000
Q1 2022

May 03, 2022

SELL
$126.46 - $235.05 $126,207 - $234,579
-998 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$225.82 - $368.51 $62,100 - $101,340
275 Added 38.04%
998 $253,000
Q3 2021

Oct 28, 2021

SELL
$221.9 - $484.47 $93,198 - $203,477
-420 Reduced 36.75%
723 $278,000
Q2 2021

Jul 27, 2021

BUY
$129.91 - $234.98 $148,487 - $268,582
1,143 New
1,143 $269,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Capital Investment Advisory Services, LLC Portfolio

Follow Capital Investment Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisory Services, LLC with notifications on news.